News ArchivesRead News

Your Weekly News Update for the Week of 11.25.19

Monday November 25, 2019
Researchers Uncover New Molecular Drivers of Parkinson's
Medical Xpress
Some cases of Parkinson's are directly caused by genetic mutations, but these are rare. Approximately 80 percent of cases have no known cause, and though there are some genes that may slightly increase an individual's risk of developing the condition, the biological impacts of these genes remain unclear. This study uncovers greater understanding for potential treatments and diagnostics of idiopathic Parkinson's.
Accelerating Medicines Partnership Program for Parkinson’s Launches New Data Portal
The Accelerating Medicines Partnership (AMP) program for Parkinson's disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to develop effective therapies for the disease. The portal enables researchers to study complex data sets and perform genome-wide analyses at a scale previously impossible.
Support Grows Nationwide for Medical Device to Improve Communication in Parkinson's
Medical Xpress
"Since the wearable device elicits a reflex, the patient does not need to remember to use therapy techniques to communicate in everyday life," said Jessica Huber, a professor in Purdue's Department of Speech, Language, and Hearing Sciences, who developed SpeechVive.
"When people with Parkinson's cannot be heard or understood, they withdraw from communication exchanges, leading to social isolation. This device makes it possible for patients to continue to communicate with their loved ones well into their life."